Collette Houston

TL;DR: Although the combination of 5‐FU and IFN in patients with advanced colorectal carcinoma has some activity, the regimen was toxic, and the observed response rate was not substantially superior to alternative 5-FU programs.

TL;DR: In this paper, the authors evaluated the utility of quality-of-life assessment in two phase II clinical trials of patients receiving paclitaxel (Taxol) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) as salvage therapy for metastatic breast cancer.

TL;DR: Although generally less toxic than cisplatin‐containing regimens, carboplatin and vinblastine is also less active in the treatment of squamous cell carcinoma of the esophagus, and Hematologic toxicity with this regimen was severe in patients who had received prior RT.

TL;DR: The COVID-19 Research Committee at Memorial Sloan Kettering Cancer Center (MSK) as discussed by the authors was created as a "one-stop" committee to provide a comprehensive review of clinical research related to COVID19, including scientific review mandated by the Cancer Center Support Grant (CCSG) guidelines.